Eden Prairie, MN – According to filings with the U.S. Securities and Exchange Commission, NeuroOne Medical Technologies is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Dave Rosa played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson’s Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.

To learn more about NeuroOne Medical Technologies, visit http://www.neurooneinc.com/

Contact:
Dave Rosa, President and Chief Executive Officer
952-426-1383
daver@neurooneinc.com
https://www.linkedin.com/in/daverosa/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved